Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 19;15(5):1197.
doi: 10.3390/v15051197.

Association of Polymorphisms of IL-6 Pathway Genes (IL6, IL6R and IL6ST) with COVID-19 Severity in an Amazonian Population

Fabíola Brasil Barbosa Rodrigues  1   2 , Rosilene da Silva  1   2 , Erika Ferreira Dos Santos  1   2 , Mioni Thieli Figueiredo Magalhães de Brito  1 , Andréa Luciana Soares da Silva  1 , Mauro de Meira Leite  1 , Flávia Póvoa da Costa  1   2 , Maria de Nazaré do Socorro de Almeida Viana  1   2 , Kevin Matheus Lima de Sarges  1   2 , Marcos Henrique Damasceno Cantanhede  1   2 , Adriana de Oliveira Lameira Veríssimo  3 , Mayara da Silva Carvalho  3 , Daniele Freitas Henriques  4 , Carla Pinheiro da Silva  4 , Igor Brasil Costa  5 , Juliana Abreu Lima Nunes  5 , Iran Barros Costa  5 , Giselle Maria Rachid Viana  6 , Maria Alice Freitas Queiroz  7 , Sandra Souza Lima  7 , Jeferson da Costa Lopes  2   7 , Maria Karoliny da Silva Torres  2   7 , Izaura Maria Vieira Cayres Vallinoto  2   7 , Carlos David Araújo Bichara  2   7 , Antonio Carlos Rosário Vallinoto  7 , Eduardo José Melo Dos Santos  1
Affiliations

Association of Polymorphisms of IL-6 Pathway Genes (IL6, IL6R and IL6ST) with COVID-19 Severity in an Amazonian Population

Fabíola Brasil Barbosa Rodrigues et al. Viruses. .

Abstract

Interleukin-6 has been recognized as a major role player in COVID-19 severity, being an important regulator of the cytokine storm. Hence, the evaluation of the influence of polymorphisms in key genes of the IL-6 pathway, namely IL6, IL6R, and IL6ST, may provide valuable prognostic/predictive markers for COVID-19. The present cross-sectional study genotyped three SNPs (rs1800795, rs2228145, and rs7730934) at IL6. IL6R and IL6ST genes, respectively, in 227 COVID-19 patients (132 hospitalized and 95 non-hospitalized). Genotype frequencies were compared between these groups. As a control group, published data on gene and genotype frequencies were gathered from published studies before the pandemic started. Our major results point to an association of the IL6 C allele with COVID-19 severity. Moreover, IL-6 plasmatic levels were higher among IL6 CC genotype carriers. Additionally, the frequency of symptoms was higher at IL6 CC and IL6R CC genotypes. In conclusion, the data suggest an important role of IL6 C allele and IL6R CC genotype on COVID-19 severity, in agreement with indirect evidence from the literature about the association of these genotypes with mortality rates, pneumonia, and heightening of protein plasmatic levels pro-inflammatory driven effects.

Keywords: COVID-19; IL6; IL6R; IL6ST; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest in conducting this project.

References

    1. Ladds E., Rushforth A., Wieringa S., Taylor S., Rayner C., Husain L., Greenhalgh T. Persistent Symptoms after COVID-19: Qualitative Study of 114 ‘Long COVID’ Patients and Draft Quality Criteria for Services. BMC Health Serv. Res. 2020;20:1144. doi: 10.1186/s12913-020-06001-y. - DOI - PMC - PubMed
    1. Wolf J., Rose-John S., Garbers C. Interleukin-6 and its receptors: A highly regulated and dynamic system. Cytokine. 2014;70:11–20. doi: 10.1016/j.cyto.2014.05.024. - DOI - PubMed
    1. van de Veerdonk F.L., Giamarellos-Bourboulis E., Pickkers P., Derde L., Leavis H., van Crevel R., Engel J.J., Wiersinga W.J., Vlaar A.P.J., Shankar-Hari M., et al. A guide to immunotherapy for COVID-19. Nat. Med. 2022;28:39–50. doi: 10.1038/s41591-021-01643-9. - DOI - PubMed
    1. Lim P.C., Wong K.L., Rajah R., Chong M.F., Chow T.S., Subramaniam S., Lee C.Y. Comparing the efficacy of tocilizumab with corticosteroid therapy in treating COVID-19 patients: A systematic review and meta-analysis. DARU J. Pharm. Sci. 2022;30:211–228. doi: 10.1007/s40199-021-00430-8. - DOI - PMC - PubMed
    1. Smith A.J., Humphries S.E. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev. 2009;20:43–59. doi: 10.1016/j.cytogfr.2008.11.006. - DOI - PubMed

Publication types